A student-run resource for reliable reports on the latest law and technology news

Comcast as a Media Powerhouse: A Threat to Consumers?
By Insue Kim – Edited by Suzanne Van Arsdale

Comcast has proposed to acquire Time Warner Cable for $45.2 billion in stock, in a merger that could have far-reaching implications for the media and communications industry. Comcast hopes the merger will further its longstanding strategy of growing into a broadband and media powerhouse. Critics voice concerns about consolidation of power, and analysts highlight Comcast’s powerful lobbying operation in Washington.

Read More...

Posted On Feb - 23 - 2014 Add Comments READ FULL POST

Innovator’s Patent Agreement: Defensive Patenting Strategies in the Software Industry

Written by: Suzanne Van Arsdale
Edited by: Michelle Sohn

On May 21, 2013, Twitter launched version 1.0 of the Innovator’s Patent Agreement (“IPA”), which formalizes a company’s commitment to non-offensive patenting and leaves some control in the hands of inventors. This Comment addresses the incentives for and legal implications of adopting the IPA, software industry concerns and current practices, and other defensive patenting mechanisms.

Read More...

Posted On Aug - 11 - 2013 Comments Off READ FULL POST

Unwanted Exposure: Civil and Criminal Liability for Revenge Porn Hosts and Posters

Written by: Susanna Lichter
Edited by: Suzanne Van Arsdale

Hollie Toups, the first named plaintiff in Toups v. GoDaddy, was harassed for weeks after nude pictures of her appeared on the website Texxxan.com alongside her real name and a link to her Facebook profile. When Toups requested that Texxxan.com remove the pictures, she was told by the website that they could help in exchange for her credit card information.[i] Texxxan.com is a “revenge porn” or “involuntary porn” website.[ii]

Read More...

Posted On May - 28 - 2013 2 Comments READ FULL POST

Federal Circuit Finds Bayer’s Yaz Birth Control Patent Invalid for Obviousness

Bayer Healthcare Pharm., Inc. v. Watson Pharm., Inc.
By Erica Larson – Edited by Suzanne Van Arsdale

The Court of Appeals for the Federal Circuit reversed the judgment of the Nevada District Court, which ruled that claims 13 and 15 of Bayer Healthcare Pharmaceuticals, Inc. and Bayer Schering Pharma AG (“Bayer”) U.S. Patent RE37,564 were not invalid for obviousness. The patent claimed a combination of synthetic hormones and dosing regimens used by Bayer in the Yaz birth control pill.

Read More...

Posted On Apr - 30 - 2013 Comments Off READ FULL POST

Supreme Court Hears Oral Arguments on Reverse Payments to Generic Drug Manufacturers

FTC v. Actavis, Inc.
By Suzanne Van Arsdale – Edited by Jennifer Wong

On Monday, March 25, the Supreme Court heard oral arguments in FTC v. Actavis, Inc., to determine the legality, under antitrust laws, of patent litigation settlements made by the maker of a brand-name drug to the maker of a generic competitor to keep the generic off the market temporarily, known as a “reverse payment agreement” or “pay for delay.”

Read More...

Posted On Apr - 3 - 2013 Comments Off READ FULL POST
  • RSS
  • Facebook
  • Twitter
  • GooglePlay
Photo By: Images Money - CC BY 2.0

DOJ Indicts Nine for

By Emma Winer – Edited by Sheri Pan [caption id="attachment_4373" align="alignleft" ...

Photo By: archie4oz - CC BY 2.0

European Court of Ju

By Paul Klein – Edited by Alex Shank [caption id="attachment_4363" align="alignleft" ...

Photo By: Kyle Nishioka - CC BY 2.0

Google to Supreme Co

By Michael Shammas – Edited by Mary Schnoor [caption id="attachment_4353" align="alignleft" ...

Photo By: Mozilla in Europe - CC BY 2.0

Mozilla Announces Re

By Sheri Pan – Edited by Corey Omer [caption id="attachment_4341" align="alignleft" ...

Icon-news

Flash Digest: News I

By Emma Winer Third Circuit Vacates Hacker Conviction for Improper Venue The ...